undamentalytics Newsletter
Sign in

Ardelyx, Inc. income statement

In fiscal 2025, Ardelyx, Inc. reported revenue of $407m, up 22.1% on the year before, operating income of −$41.0m (a -10.1% margin) and net income of −$61.6m, or −$0.26 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2012Dec 20122013Dec 20132014Dec 20142015Dec 20152017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue5293224423581052124334407451
Cost of revenue————80101418514025
Gross profit———2434257948107283368425
Research and development1028264075697265913536527287
Selling, general and administrative————————7277134259337374
General and administrative4471423242433——————
Operating income−9−3−2−29−65−91−91−91−154−64−63−28−41−35
Interest expense—————465535132022
Income before tax−10−6−3−30−63−91−95−94−158−67−66−39−61−55
Income tax—00−01000001010
Net income−10−7−3−30−64−91−95−94−158−67−66−39−62−56
Diluted EPS−$5.66−$2.91−$0.15−$0.65−$1.36−$1.62−$1.47−$1.05−$1.52−$0.42−$0.30−$0.17−$0.26−$0.23
Diluted shares (average)2m2m20m46m47m56m64m90m104m159m219m235m241m245m
EBITDA−8−2−1−29−63−88−89−88−152−63−62−26−38−32

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ARDX vs CRMDARDX vs ARQTARDX vs KRYS

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Ardelyx, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Ardelyx, Inc.